Tonix Pharmaceuticals Holding (TNXP) Raw Materials (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Raw Materials for 3 years, with the latest figure at $2.5 million in Q4 2025.

• On a quarterly basis, Raw Materials fell 18.4% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a 18.4% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, down 18.4% from the prior year.
• Raw Materials was $2.5 million for Q4 2025 at Tonix Pharmaceuticals Holding, up from $2.5 million in the prior quarter.
• The five-year high for Raw Materials was $3.6 million in Q4 2023, with the low at $2.3 million in Q2 2025.
• Average Raw Materials over 3 years is $2.9 million, with a median of $2.7 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Raw Materials fell 14.95% in 2024, then declined 25.82% in 2025.
• Over 3 years, Raw Materials stood at $3.6 million in 2023, then decreased by 14.95% to $3.1 million in 2024, then retreated by 18.4% to $2.5 million in 2025.
• The last three Raw Materials figures came in at $2.5 million (Q4 2025), $2.5 million (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.